Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Receivables (2024 - 2025)

Connect Biopharma Holdings' Change in Receivables history spans 2 years, with the latest figure at $17000.0 for Q3 2025.

  • For Q3 2025, Change in Receivables fell 99.66% year-over-year to $17000.0; the TTM value through Sep 2025 reached -$5.0 million, changed N/A, while the annual FY2024 figure was $789000.0, N/A changed from the prior year.
  • Change in Receivables for Q3 2025 was $17000.0 at Connect Biopharma Holdings, up from -$8000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $5.0 million in Q3 2024 and bottomed at -$4.2 million in Q4 2024.